SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-148627
Filing Date
2016-11-07
Accepted
2016-11-07 16:29:00
Documents
2
Period of Report
2016-11-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1609
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3368
  Complete submission text file 0001209191-16-148627.txt   6465
Mailing Address 50 MILK STREET 16TH FLOOR BOSTON MA 02109
Business Address 50 MILK STREET 16TH FLOOR BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Issuer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE, 5TH FLOOR CAMBRIDGE MA 02140
Business Address
Cooper Ronald Harold Wilfred (Reporting) CIK: 0001676880 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33451 | Film No.: 161978486